Connect with us

Policy

Pandemic “far From Completion”: WHO

Published

on

Credit: PIXTA / CC0 public domain

The COVID-19 crisis is not over yet, said the World Health Organization’s emergency committee called for research on next-generation vaccines for long-term pandemic management on Tuesday.

19 members Committee Meetings are held every three months to discuss pandemics and make recommendations.

In a statement at a four-hour virtual conference on Friday, WHO said, “We have made progress with increased intake of COVID-19 vaccines and therapeutics, but the analysis of the current situation and predictive models is still pandemic. It shows that there is no such thing. “

The Commission called for further research on reusable masks and respiratory organs, and next-generation vaccines, diagnoses and treatments “for long-term management of pandemics.”

“Improved mask use, physical distance, hand hygiene, and ventilation of indoor spaces continue to be the key to reducing SARSCoV-2 infection,” the statement emphasized.

The Commission said a prolonged pandemic complicates humanitarian emergencies, mass migration and other crises. Therefore, countries need to revise their preparation and response plans.

It expressed concern about Africa’s challenges in tackling the pandemic, including access to vaccines, tests and treatments, and the collection and analysis of data to monitor the development of the pandemic.

Only 14 vaccination According to AFP calculations, there is a dose per 100 people in Africa.

This figure corresponds to 128 doses in the United States and Canada. 113 in Europe. 106 in Latin America and the Caribbean. 103 in Oceania; 102 in Asia; 78 in the Middle East.

The Commission first declared on January 30, last year that the virus was a Public Health Emergency of International Concern (PHEIC). This is the best alarm that WHO can issue.

The Commission should not require proof of vaccination for overseas travel, or should be the only condition “given limited worldwide access and unfair distribution of the COVID-19 vaccine”. I kept the claim that it was.

Instead, countries should consider “a risk-based approach to facilitating international travel by removing or changing measures such as testing and quarantine requirements as needed.”

The Commission also called on countries to approve all vaccines that have been granted an emergency use authorization by WHO.

WHO condemns “shocking inequality” in access to vaccines

(C) 2021 AFP

Quote: Pandemic “Far to Completion”: WHO (October 26, 2021) obtained October 26, 2021 from https://medicalxpress.com/news/2021-10-pandemic-finished.html

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.

Pandemic “far from completion”: WHO

Source link Pandemic “far from completion”: WHO

The post Pandemic “far from completion”: WHO appeared first on Florida News Times.

Read More

Article: floridanewstimes.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Policy

Antibodies Help Control Harmful Forms of Intestinal Fungi

Published

on

Credit: AIXabay / CC0 public domain

Antibodies protection against harmful forms of fungi in the intestine can be disrupted in some patients with Crohn’s disease, a condition caused by chronic inflammation of the intestine, according to a new study by researchers at Weill Cornell Medicine. ..

Previous studies have shown that the immune system plays an important role in maintaining a healthy balance of gut bacteria.The new study was published on November 22nd Nature microbiology, Senior author Iliyan Iliev, associate professor of immunology in medicine, and his team investigated whether it could also play a role in the management of intestinal fungi.

Unlike bacteria, fungi can change shape depending on environmental conditions, and certain forms are harmful to humans. In particular, a type of fungus called Candida albicans changes from a non-pathogenic yeast type to a type that produces hyphae that can invade tissues and cause damage.

Researchers have found that antibodies secreted in the intestine help control the etiology of candida albicans in healthy people, disabling this protective mechanism in people with Crohn’s disease and harmful overgrowth of pathogenic fungi. I have discovered that it can cause. Candida albicans intestinal excess is associated with inflammatory bowel disease and several other conditions that directly or indirectly affect the gastrointestinal tract.

“Anti-intestinal antibodies are involved in maintaining certain intestinal fungi, such as Candida albicans, in a benign, so-called symbiotic form,” said Iriev, a scientist at the Zil Roberts Institute for Inflammatory Intestines. I found that. ” Weil Cornell Medical illness. “This process is interrupted in patients with Crohn’s disease.”

In their experiments, researchers found that an antibody called secretory immunoglobulin A (slgA) in the feces of healthy mice selectively binds to the form of C. albicans in hyphae and stops its spread. discovered. They also found that these antibodies also bind to the hyphae of healthy human feces.

“These antibodies preferentially bind to the hyphae,” said Itai Delon, a PhD student in the lab. Specifically, they bind to sites on the hyphae and produce the virulence factors that these fungi use to harm host tissues. However, the antibody does not preferentially bind to harmless yeast. This suggests that antibodies may help the body maintain a healthy balance of intestinal fungi by preventing the inheritance of harmful forms of fungi.

Researchers also found that patients with Crohn’s disease, who develop severe inflammation of the colon and small intestine, have higher levels of antifungal antibodies in their blood compared to healthy adults. However, these antibodies do not appear to be secreted at high levels in the intestine to counter Candida albicans hyphae. Samples from the colon of these patients reveal an excess of fungi with hyphae.

“Impairment of this regulatory mechanism in mice and patients with Crohn’s disease can contribute to increased hyphal growth in the intestine,” Iriev said.

When researchers added antifungal antibodies to human cells grown in culture with C. albicans, the fungi produced fewer hyphae.

“These antifungal antibodies appear to have some degree of” disarmament “in the hyphae,” Delon said.

The result is that the therapeutic search for antifungal antibodies can be C. It suggests that it may be a way to help patients who develop overgrowth of albicans. Not all patients with this inflammatory bowel disease have overgrowth of this type of fungus, but some may be an important cause of the disease, Iriev said.

“The intestinal fungi in the gut, especially the Candida albicans community, form our immunity,” Iriev said. “We are developing these antibodies and they appear to play a protective role in certain situations.”

The major immune fungus of the intestine against infection

For more information:
Jordan Hindson, Intestinal Mycoviota Modulates Immunity mediated by Antifungal Antibodies, Nature Reviews Gastroenterology & Hepatology (2021). DOI: 10.1038 / s41575-021-00439-z

Provided by
Cornell University

Quote: Antibodies help control harmful forms of enteric fungi obtained on November 30, 2021 from https: //medicalxpress.com/news/2021-11-antibodies-gut-fungi.html ( November 30, 2021)

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. Content is provided for informational purposes only.

Antibodies help control harmful forms of intestinal fungi

Source link Antibodies help control harmful forms of intestinal fungi

The post Antibodies help control harmful forms of intestinal fungi appeared first on Florida News Times.

Read More

Source Here: floridanewstimes.com

Continue Reading

Policy

Researchers Are Developing Fast, Accurate Tests to Detect Viruses Like SARS-COV-2

Published

on

Credit: Unsplash / CC0 public domain

Researchers at the University of Central Florida have developed a device that detects viruses such as SARS-COV-2 in the body more accurately and as quickly as the rapid detection tests commonly used today.

Optical sensors use nanotechnology to accurately identify viruses in seconds. Blood sample..Researchers say the device can tell if someone has it with 95% accuracy virusSignificant improvements to the current rapid testing, which experts warn, may be less accurate. Testing for the virus is important for early treatment and prevention of the spread of the virus.

The results are detailed in a new study in the journal Nano letter..

Researchers tested the device with a sample of dengue virus, a mosquito-borne pathogen that causes dengue fever and poses a threat to people in the tropics. However, this technology can be easily adapted to detect other viruses such as SARS-COV-2, says Debashis Chanda, a professor at UCF’s NanoScience Technology Center, co-author of the study. ..

“High-sensitivity optical sensors, along with the rapid manufacturing approach used in this task, can transform this promising technology with a high degree of specificity and accuracy for detection of any virus, including SARS-COV-2 and its mutations. I promise, “says Chanda. “Here we have demonstrated a reliable technique that combines a genetic code such as PCR with an optical system on a chip to accurately detect the virus directly from the blood.”

This device closely matches the accuracy of gold standard PCR-based tests, but with near-instantaneous results rather than days of reception. Its accuracy is significantly improved over the current rapid antigen test warned by the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, and is inaccurate if the viral load is low or if the test instructions are not followed correctly. Results may occur.

The device works with a gold nanoscale pattern that reflects the virus’s signature that is set to detect on blood samples. Different viruses can be detected by using different DNA sequences that selectively target a particular virus.

The key to device performance is the ability to detect viruses directly from blood samples without the need for sample preparation or purification. This speeds up testing and improves accuracy.

“Most of the biosensor demonstrations in the literature use buffers as a test matrix to contain targeted analytes,” says Chanda. “But these approaches are not practical in real-world applications. Complex body fluids containing target biomarkers, such as blood, are the main cause of sensing, while at the same time the main cause of protein contamination leading to sensor failure. Because it is the cause. “

Researchers have confirmed the effectiveness of the device in multiple tests using different viral concentration levels and solution environments, including the presence of non-target viral biomarkers.

Abraham Vazquez Guardard, a postdoc at Northwestern University who was the lead author of the study and worked as a postdoctoral student in Chanda’s lab, said he was excited about the possibility.

“There was a previous demonstration of optical biosensing with human serum, but it requires offline complex and dedicated sample preparation by skilled personnel. This is a product not available in regular point of care applications.” Vazquez-Guardado says. “This study demonstrates for the first time an integrated device that separates plasma from blood and detects target viruses without pretreatment, with potential for practical use in the near future.”

According to Chanda, the next step in the study will include adapting the device to detect more viruses.

Portable, Affordable, Accurate, Fast: Team Invents New COVID-19 Test

For more information:
Abraham Vazquez-Guardado et al., DNA-modified plasmon sensor for detecting viral biomarkers directly from blood, Nano letter (2021). DOI: 10.1021 / acs.nanolett.1c01609

Quote: The researchers obtained SARS-COV-2 (2021, November 29, 2021) from https: //phys.org/news/2021-11-rapid-highly-accurate-viruses- on November 29, 2021. ) Develop fast and accurate tests to detect viruses like. sars-cov-.html

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. Content is provided for informational purposes only.

Researchers are developing fast, accurate tests to detect viruses like SARS-COV-2

Source link Researchers are developing fast, accurate tests to detect viruses like SARS-COV-2

The post Researchers are developing fast, accurate tests to detect viruses like SARS-COV-2 appeared first on Florida News Times.

Read More

Source Here: floridanewstimes.com

Continue Reading

Policy

Drivers to Face Traffic Delays This Week on I-25 Near Colorado Springs

Published

on

A paving project on Interstate 25 south of Colorado Springs will delay traffic during the next several days, according to a Colorado Department of Transportation news release.

The paving project, which includes filling potholes with asphalt and making road repairs between Santa Fe Boulevard and South Academy Boulevard near Fort Carson, will reduce traffic to a single lane during daytime hours (9 a.m.-3 p.m.), with a speed limit of 55 mph, Tuesday through Thursday, the agency said.

Drivers are encouraged to use alternate routes during the maintenance period and those who drive through the construction zone are advised to slow down, allow extra space between vehicles and build in extra travel time. Fines will be doubled in the work zones, the release said.

1 killed in Pueblo County crash

The maintenance is a facet of a larger project designed to improve safety around military facilities in the Pikes Peak Region, the release said.

For more traffic information visit COtrip.org.

Colorado Springs weather: Record-breaking temps possible Monday, throughout week



Read More

Source Here: gazette.com

Continue Reading

Trending

BaypointNews.com